Retinocochleocerebral Vasculopathy Presented as Bilateral Neovascular Glaucoma
Clinical Case Reports, Volume 13, Issue 1, January 2025.ABSTRACT Susac is a rare systemic disease characterized by ischemic events involving the cochlea, brain, and retina. Delay in the diagnosis leads to sight‐threatening complications such as neovascular glaucoma.
Mehrdad Motamed Shariati +2 more
wiley +1 more source
Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons
Molecular Neurodegeneration, 2011 Background Brimonidine is a common drug for lowering ocular pressure and may directly protect retinal ganglion cells in glaucoma. The disease involves early loss of retinal ganglion cell transport to brain targets followed by axonal and somatic ...
Crish Samuel D +4 more
doaj +1 more source
New and emerging technologies for the treatment of inherited retinal diseases: a horizon scanning review. [PDF]
, 2015 The horizon scanning review aimed to identify new and emerging technologies in development that have the potential to slow or stop disease progression and/or reverse sight loss in people with inherited retinal diseases (IRDs).
Michaelides, M +4 more
core
Prevalence and clinical characteristics of Charles Bonnet syndrome in Madrid, Spain [PDF]
, 2014 Purpose: Charles Bonnet syndrome (CBS) is a condition characterized by development of visual hallucinations in patients with no cognitive impairment and significant loss of vision mainly caused by age-related macular degeneration (AMD) or glaucoma ...
García Feijoo, Julián +6 more
core +2 more sources
Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 1, Page 181-188, January 2025.Abstract Background Understanding the role of calcitonin gene‐related peptide (CGRP) in the pathogenesis of rosacea might provide new therapeutic avenues for individuals with this disease. Objective To compare plasma levels of CGRP between individuals with rosacea and healthy controls.
Nita K. F. Wienholtz +6 more
wiley +1 more source
Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes
Indian Journal of Ophthalmology, 2003 Purpose: To compare the short-term efficacy and safety of topical latanoprost and brimonidine in Indian eyes. Materials and Methods: Twenty-eight patients with ocular hypertension, primary open-angle, pseudoexfoliation or pigmentary glaucoma were ...
Thomas Ravi +5 more
doaj
Effect of brimonidine on central corneal thickness in normal tension glaucoma patients [PDF]
, 2019 Background: Brimonidine is a potent ocular hypotensive agent widely used in glaucoma treatment. A reduction in central corneal thickness can lead to an underestimation of intraocular pressure by Goldmann applanation tonometry and vice versa.
K., Praveena K. +2 more
core +2 more sources
Brimonidine in the treatment of glaucoma and ocular hypertension
Therapeutics and Clinical Risk Management, 2006 Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively lowers IOP and is useful as monotherapy, adjunctive therapy, and replacement therapy in open-angle glaucoma and ocular hypertension.
openaire +4 more sources
Effect of latanoprost 0.005% and brimonidine tartrate 0.2% on pulsatile ocular blood flow in normal tension glaucoma [PDF]
, 2002 Catherine Liu +5 more
openalex +1 more source
Failure of naloxone to reverse brimonidine-induced coma in an infant [PDF]
, 2002 Jaques Sztajnbok
openalex +1 more source